Our work extends from the laboratory to wide-scale community studies with a focus on diagnosis, prevention and treatment of diabetes and cardiovascular disease.
Information to help you maintain your physical activity in the face of COVID-19 restrictions
We are testing the additional effects of a tablet that is already proven to benefit kidney function.
New research has highlighted a significant gender treatment gap for atrial fibrillation (AF), a common heart rhythm disorder which is projected to increase by 60 per cent over the next 15 years and dramatically heightens the risk of stroke and death.
Imaging athletes’ hearts during exercise, not at rest.
Near-infrared fluorescence light can detect the atherosclerotic plaques that lead to heart attack and stroke.
Biomarkers that highlight toxic fats in the liver.
Benefits for type 2 diabetes of interrupting prolonged sitting.
NLRP1 Obesity and diabetes ‘sensor’ protein identified.
IL-1 The discovery that fat in obese people causes the release of a molecule called IL-1.
With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.Find out more